Inpatient drug utilization in Europe: nationwide data sources and a review of publications on a selected group of medicines (PROTECT project).
Identifieur interne : 000336 ( PubMed/Checkpoint ); précédent : 000335; suivant : 000337Inpatient drug utilization in Europe: nationwide data sources and a review of publications on a selected group of medicines (PROTECT project).
Auteurs : M Nica Sabaté [Espagne] ; Pili Ferrer ; Elena Ballarín ; Marietta Rottenkolber ; Justyne Amelio ; Sven Schmiedl ; Robert Reynolds ; Olaf Klungel ; Luisa Ibá EzSource :
- Basic & clinical pharmacology & toxicology [ 1742-7843 ] ; 2015.
English descriptors
- KwdEn :
- MESH :
- geographic : Europe.
- statistics & numerical data : Drug Utilization, Hospitals, Practice Patterns, Physicians'.
- Databases, Factual, Humans, Inpatients.
Abstract
Drug utilization (DU) studies in inpatient settings at a national level are rarely conducted. The main objective of this study was to review the general information on hospital medicine management in Europe and to report on the availability and characteristics of nationwide administrative drug consumption databases. A secondary objective was to perform a review of published studies on hospital DU of a group of selected drugs, focusing on methodological characteristics (ATC/DDD). General information on hospital drug management was retrieved from several websites, nationwide administrative drug consumption databases and reports published by governmental organizations. A PubMed search was conducted using keywords related to the selected group of drugs AND 'hospital drug utilization'. The data sources for hospital DU information varied widely and included 14 databases from 25 reviewed countries. Bulgaria, Croatia, Denmark, Estonia, Finland, France, Hungary, Iceland, Latvia, Norway and Sweden obtain information on inpatient DU at a national level from wholesalers/manufacturers. In Belgium, Italy and Portugal, drugs dispensed to patients in hospitals are registered at a national level. Data are freely available online only for Denmark and Iceland. From the PubMed search, of a total of 868 retrieved studies, only 13 studies used the ATC/DDD methodology. Although the number of DDD/100 bed-days was used in four studies, other units of measure were also used. The type of information provided for the inpatient sector allowed primarily for conducting DU research at an aggregated data level. The existence of national administrative structures to monitor hospital DU would contribute to promoting the rational use of medicines and improving the safety and quality of prescribing.
DOI: 10.1111/bcpt.12358
PubMed: 25420967
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:25420967Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Inpatient drug utilization in Europe: nationwide data sources and a review of publications on a selected group of medicines (PROTECT project).</title><author><name sortKey="Sabate, M Nica" sort="Sabate, M Nica" uniqKey="Sabate M" first="M Nica" last="Sabaté">M Nica Sabaté</name><affiliation wicri:level="3"><nlm:affiliation>Fundació Institut Català de Farmacologia, Barcelona, Spain; Department of Clinical Pharmacology, University Hospital Vall d'Hebron, Barcelona, Spain; Department of Pharmacology, Toxicology and Clinical Therapeutics, Hospital Universitari Vall d'Hebron, Univ Autònoma de Barcelona, Barcelona, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Fundació Institut Català de Farmacologia, Barcelona, Spain; Department of Clinical Pharmacology, University Hospital Vall d'Hebron, Barcelona, Spain; Department of Pharmacology, Toxicology and Clinical Therapeutics, Hospital Universitari Vall d'Hebron, Univ Autònoma de Barcelona, Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName></affiliation></author><author><name sortKey="Ferrer, Pili" sort="Ferrer, Pili" uniqKey="Ferrer P" first="Pili" last="Ferrer">Pili Ferrer</name></author><author><name sortKey="Ballarin, Elena" sort="Ballarin, Elena" uniqKey="Ballarin E" first="Elena" last="Ballarín">Elena Ballarín</name></author><author><name sortKey="Rottenkolber, Marietta" sort="Rottenkolber, Marietta" uniqKey="Rottenkolber M" first="Marietta" last="Rottenkolber">Marietta Rottenkolber</name></author><author><name sortKey="Amelio, Justyne" sort="Amelio, Justyne" uniqKey="Amelio J" first="Justyne" last="Amelio">Justyne Amelio</name></author><author><name sortKey="Schmiedl, Sven" sort="Schmiedl, Sven" uniqKey="Schmiedl S" first="Sven" last="Schmiedl">Sven Schmiedl</name></author><author><name sortKey="Reynolds, Robert" sort="Reynolds, Robert" uniqKey="Reynolds R" first="Robert" last="Reynolds">Robert Reynolds</name></author><author><name sortKey="Klungel, Olaf" sort="Klungel, Olaf" uniqKey="Klungel O" first="Olaf" last="Klungel">Olaf Klungel</name></author><author><name sortKey="Iba Ez, Luisa" sort="Iba Ez, Luisa" uniqKey="Iba Ez L" first="Luisa" last="Ibá Ez">Luisa Ibá Ez</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25420967</idno><idno type="pmid">25420967</idno><idno type="doi">10.1111/bcpt.12358</idno><idno type="wicri:Area/PubMed/Corpus">000382</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000382</idno><idno type="wicri:Area/PubMed/Curation">000379</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000379</idno><idno type="wicri:Area/PubMed/Checkpoint">000379</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000379</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Inpatient drug utilization in Europe: nationwide data sources and a review of publications on a selected group of medicines (PROTECT project).</title><author><name sortKey="Sabate, M Nica" sort="Sabate, M Nica" uniqKey="Sabate M" first="M Nica" last="Sabaté">M Nica Sabaté</name><affiliation wicri:level="3"><nlm:affiliation>Fundació Institut Català de Farmacologia, Barcelona, Spain; Department of Clinical Pharmacology, University Hospital Vall d'Hebron, Barcelona, Spain; Department of Pharmacology, Toxicology and Clinical Therapeutics, Hospital Universitari Vall d'Hebron, Univ Autònoma de Barcelona, Barcelona, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Fundació Institut Català de Farmacologia, Barcelona, Spain; Department of Clinical Pharmacology, University Hospital Vall d'Hebron, Barcelona, Spain; Department of Pharmacology, Toxicology and Clinical Therapeutics, Hospital Universitari Vall d'Hebron, Univ Autònoma de Barcelona, Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName></affiliation></author><author><name sortKey="Ferrer, Pili" sort="Ferrer, Pili" uniqKey="Ferrer P" first="Pili" last="Ferrer">Pili Ferrer</name></author><author><name sortKey="Ballarin, Elena" sort="Ballarin, Elena" uniqKey="Ballarin E" first="Elena" last="Ballarín">Elena Ballarín</name></author><author><name sortKey="Rottenkolber, Marietta" sort="Rottenkolber, Marietta" uniqKey="Rottenkolber M" first="Marietta" last="Rottenkolber">Marietta Rottenkolber</name></author><author><name sortKey="Amelio, Justyne" sort="Amelio, Justyne" uniqKey="Amelio J" first="Justyne" last="Amelio">Justyne Amelio</name></author><author><name sortKey="Schmiedl, Sven" sort="Schmiedl, Sven" uniqKey="Schmiedl S" first="Sven" last="Schmiedl">Sven Schmiedl</name></author><author><name sortKey="Reynolds, Robert" sort="Reynolds, Robert" uniqKey="Reynolds R" first="Robert" last="Reynolds">Robert Reynolds</name></author><author><name sortKey="Klungel, Olaf" sort="Klungel, Olaf" uniqKey="Klungel O" first="Olaf" last="Klungel">Olaf Klungel</name></author><author><name sortKey="Iba Ez, Luisa" sort="Iba Ez, Luisa" uniqKey="Iba Ez L" first="Luisa" last="Ibá Ez">Luisa Ibá Ez</name></author></analytic><series><title level="j">Basic & clinical pharmacology & toxicology</title><idno type="eISSN">1742-7843</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Databases, Factual</term><term>Drug Utilization (statistics & numerical data)</term><term>Europe</term><term>Hospitals (statistics & numerical data)</term><term>Humans</term><term>Inpatients</term><term>Practice Patterns, Physicians' (statistics & numerical data)</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Europe</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Drug Utilization</term><term>Hospitals</term><term>Practice Patterns, Physicians'</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Databases, Factual</term><term>Humans</term><term>Inpatients</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Drug utilization (DU) studies in inpatient settings at a national level are rarely conducted. The main objective of this study was to review the general information on hospital medicine management in Europe and to report on the availability and characteristics of nationwide administrative drug consumption databases. A secondary objective was to perform a review of published studies on hospital DU of a group of selected drugs, focusing on methodological characteristics (ATC/DDD). General information on hospital drug management was retrieved from several websites, nationwide administrative drug consumption databases and reports published by governmental organizations. A PubMed search was conducted using keywords related to the selected group of drugs AND 'hospital drug utilization'. The data sources for hospital DU information varied widely and included 14 databases from 25 reviewed countries. Bulgaria, Croatia, Denmark, Estonia, Finland, France, Hungary, Iceland, Latvia, Norway and Sweden obtain information on inpatient DU at a national level from wholesalers/manufacturers. In Belgium, Italy and Portugal, drugs dispensed to patients in hospitals are registered at a national level. Data are freely available online only for Denmark and Iceland. From the PubMed search, of a total of 868 retrieved studies, only 13 studies used the ATC/DDD methodology. Although the number of DDD/100 bed-days was used in four studies, other units of measure were also used. The type of information provided for the inpatient sector allowed primarily for conducting DU research at an aggregated data level. The existence of national administrative structures to monitor hospital DU would contribute to promoting the rational use of medicines and improving the safety and quality of prescribing.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25420967</PMID><DateCreated><Year>2015</Year><Month>02</Month><Day>16</Day></DateCreated><DateCompleted><Year>2015</Year><Month>11</Month><Day>03</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1742-7843</ISSN><JournalIssue CitedMedium="Internet"><Volume>116</Volume><Issue>3</Issue><PubDate><Year>2015</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Basic & clinical pharmacology & toxicology</Title><ISOAbbreviation>Basic Clin. Pharmacol. Toxicol.</ISOAbbreviation></Journal><ArticleTitle>Inpatient drug utilization in Europe: nationwide data sources and a review of publications on a selected group of medicines (PROTECT project).</ArticleTitle><Pagination><MedlinePgn>201-11</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/bcpt.12358</ELocationID><Abstract><AbstractText>Drug utilization (DU) studies in inpatient settings at a national level are rarely conducted. The main objective of this study was to review the general information on hospital medicine management in Europe and to report on the availability and characteristics of nationwide administrative drug consumption databases. A secondary objective was to perform a review of published studies on hospital DU of a group of selected drugs, focusing on methodological characteristics (ATC/DDD). General information on hospital drug management was retrieved from several websites, nationwide administrative drug consumption databases and reports published by governmental organizations. A PubMed search was conducted using keywords related to the selected group of drugs AND 'hospital drug utilization'. The data sources for hospital DU information varied widely and included 14 databases from 25 reviewed countries. Bulgaria, Croatia, Denmark, Estonia, Finland, France, Hungary, Iceland, Latvia, Norway and Sweden obtain information on inpatient DU at a national level from wholesalers/manufacturers. In Belgium, Italy and Portugal, drugs dispensed to patients in hospitals are registered at a national level. Data are freely available online only for Denmark and Iceland. From the PubMed search, of a total of 868 retrieved studies, only 13 studies used the ATC/DDD methodology. Although the number of DDD/100 bed-days was used in four studies, other units of measure were also used. The type of information provided for the inpatient sector allowed primarily for conducting DU research at an aggregated data level. The existence of national administrative structures to monitor hospital DU would contribute to promoting the rational use of medicines and improving the safety and quality of prescribing.</AbstractText><CopyrightInformation>© 2014 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sabaté</LastName><ForeName>Mònica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Fundació Institut Català de Farmacologia, Barcelona, Spain; Department of Clinical Pharmacology, University Hospital Vall d'Hebron, Barcelona, Spain; Department of Pharmacology, Toxicology and Clinical Therapeutics, Hospital Universitari Vall d'Hebron, Univ Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrer</LastName><ForeName>Pili</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Ballarín</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Rottenkolber</LastName><ForeName>Marietta</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Amelio</LastName><ForeName>Justyne</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Schmiedl</LastName><ForeName>Sven</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Reynolds</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Klungel</LastName><ForeName>Olaf</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Ibáñez</LastName><ForeName>Luisa</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><CollectiveName>PROTECT Work Package 2</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>098504</GrantID><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/K006584/1</GrantID><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>12</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Basic Clin Pharmacol Toxicol</MedlineTA><NlmUniqueID>101208422</NlmUniqueID><ISSNLinking>1742-7835</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004363" MajorTopicYN="N">Drug Utilization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007297" MajorTopicYN="N">Inpatients</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010818" MajorTopicYN="N">Practice Patterns, Physicians'</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Alvarez</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Slattery</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kurz</LastName><ForeName>X</ForeName><Initials>X</Initials></Investigator><Investigator ValidYN="Y"><LastName>Candoere</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Durand</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Blackburn</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rottenkolber</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hasford</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stueven</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Abajo Iglesias</LastName><ForeName>F J</ForeName><Initials>FJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martin Merino</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gil</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Huerta</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Montero</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>González</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Garcia-Rodriguez</LastName><ForeName>L A</ForeName><Initials>LA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ruigomez</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Souverein</LastName><ForeName>P C</ForeName><Initials>PC</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Dijk</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Afonso</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Groot</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gardarsdottir</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Van den Ham</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Belitser</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Boer</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Groenwold</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hoes</LastName><ForeName>A W</ForeName><Initials>AW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roes</LastName><ForeName>K C B</ForeName><Initials>KC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sanni</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Uddin</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Bakker</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pestman</LastName><ForeName>W</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abbing-Krahagopian</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Vries</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Egberts</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leufkens</LastName><ForeName>H G M</ForeName><Initials>HG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Klungel</LastName><ForeName>O H</ForeName><Initials>OH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Teixidor</LastName><ForeName>I</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Bruin</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parkinson</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Campbell</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gallagher</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Staa</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ng</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bhaskaran</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Douglas</LastName><ForeName>I</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smeeth</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wing</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ranopa</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Helboe</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lyngvig</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clemensen</LastName><ForeName>A M</ForeName><Initials>AM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Engraff</LastName><ForeName>T S</ForeName><Initials>TS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hesse</LastName><ForeName>U</ForeName><Initials>U</Initials></Investigator><Investigator ValidYN="Y"><LastName>Poulsen</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rønn</LastName><ForeName>P F</ForeName><Initials>PF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Logie</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pimenta</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Davis</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Swain</LastName><ForeName>E J</ForeName><Initials>EJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abenhaim</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reynolds</LastName><ForeName>R F</ForeName><Initials>RF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gatto</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bate</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Richards</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Feudjo-Tepie</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Downey</LastName><ForeName>G F</ForeName><Initials>GF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brauer</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Amelio</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roddam</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Demol</LastName><ForeName>O</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Johansson</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Primatesta</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schlienger</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fortuny</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rivero</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Plana Hortoneda</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tatt</LastName><ForeName>I</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hannon</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Robinson</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vesanen</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schuerch</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Laporte</LastName><ForeName>J-R</ForeName><Initials>JR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ibáñez</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sabaté</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ballarín</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pérez</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ferrer</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schmiedl</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bensouda-Grimaldi</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rahaelle</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Micaleff</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>07</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25420967</ArticleId><ArticleId IdType="doi">10.1111/bcpt.12358</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Espagne</li></country><region><li>Catalogne</li></region><settlement><li>Barcelone</li></settlement></list><tree><noCountry><name sortKey="Amelio, Justyne" sort="Amelio, Justyne" uniqKey="Amelio J" first="Justyne" last="Amelio">Justyne Amelio</name><name sortKey="Ballarin, Elena" sort="Ballarin, Elena" uniqKey="Ballarin E" first="Elena" last="Ballarín">Elena Ballarín</name><name sortKey="Ferrer, Pili" sort="Ferrer, Pili" uniqKey="Ferrer P" first="Pili" last="Ferrer">Pili Ferrer</name><name sortKey="Iba Ez, Luisa" sort="Iba Ez, Luisa" uniqKey="Iba Ez L" first="Luisa" last="Ibá Ez">Luisa Ibá Ez</name><name sortKey="Klungel, Olaf" sort="Klungel, Olaf" uniqKey="Klungel O" first="Olaf" last="Klungel">Olaf Klungel</name><name sortKey="Reynolds, Robert" sort="Reynolds, Robert" uniqKey="Reynolds R" first="Robert" last="Reynolds">Robert Reynolds</name><name sortKey="Rottenkolber, Marietta" sort="Rottenkolber, Marietta" uniqKey="Rottenkolber M" first="Marietta" last="Rottenkolber">Marietta Rottenkolber</name><name sortKey="Schmiedl, Sven" sort="Schmiedl, Sven" uniqKey="Schmiedl S" first="Sven" last="Schmiedl">Sven Schmiedl</name></noCountry><country name="Espagne"><region name="Catalogne"><name sortKey="Sabate, M Nica" sort="Sabate, M Nica" uniqKey="Sabate M" first="M Nica" last="Sabaté">M Nica Sabaté</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000336 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000336 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:25420967
|texte= Inpatient drug utilization in Europe: nationwide data sources and a review of publications on a selected group of medicines (PROTECT project).
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:25420967" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonFranceV1
| This area was generated with Dilib version V0.6.29. |  |